Equillium

#药闻简讯# EQ504是一种研究性高效选择性芳烃受体（AhR）调节剂，其设计采用多模式、非免疫抑制的作用机制，可与其他炎症和免疫治疗药物形成互补。AhR对屏障器官组织的生理和免疫功能至关重要，既能维持屏障功能，促进组织修复与再生，又能通过抗炎反应调节常驻免疫细胞。EQ504的临床前特性表明，...

$Equillium(EQ)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003008  Act: 33  Size: 1 KB 网页链接

$Equillium(EQ)$ 8-K Current report, items 4.01, 5.02, 8.01, and 9.01 Accession Number: 0001193125-25-231860  Act: 34  Size: 166 KB 网页链接

$Equillium(EQ)$ 8-K Current report, item 8.01 Accession Number: 0000950170-25-113023  Act: 34  Size: 155 KB 网页链接

$Equillium(EQ)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-25-199239  Act: 33  Size: 361 KB 网页链接

$Equillium(EQ)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-25-199243  Act: 33  Size: 522 KB 网页链接

$Equillium(EQ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023570  Size: 5 KB 网页链接

$Equillium(EQ)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-209068  Act: 34  Size: 159 KB 网页链接

$Equillium(EQ)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-209063  Act: 33  Size: 14 KB 网页链接

$Equillium(EQ)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001193125-25-177510  Act: 34  Size: 649 KB 网页链接

$Equillium(EQ)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-108834  Act: 34  Size: 8 MB 网页链接

$Equillium(EQ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023569  Size: 5 KB 网页链接

$Equillium(EQ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023566  Size: 5 KB 网页链接

$Equillium(EQ)$ 8-K Current report, items 1.01, 2.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-172207  Act: 34  Size: 530 KB 网页链接

$Equillium(EQ)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-25-023567  Size: 5 KB 网页链接